bisacodyl has been researched along with Chronic Disease in 16 studies
Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Split 2-L PEG-CS plus bisacodyl was not superior to split 4-L PEG for colonoscopy bowel cleansing in patients with chronic constipation; however, it performed better than the standard regimen in terms of colonic mucosa visualization, patient acceptance and compliance." | 9.20 | 2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipation. ( Arena, M; Baccarin, A; Bargiggia, S; Fontana, P; Manes, G; Masci, E; Mazzoleni, G; Parente, F; Spinzi, G; Testoni, PA; Vailati, C, 2015) |
| "Oral bisacodyl is an effective and well-tolerated treatment for patients with chronic constipation." | 9.15 | Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. ( Gessner, U; Kamm, MA; Mueller-Lissner, S; Richter, E; Swallow, R; Wald, A, 2011) |
| "To compare the safety and efficacy of bisacodyl and sodium picosulphate in the treatment of chronic constipation over a 4-week period." | 9.12 | Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. ( Jordan, CC; Kamm, MA; Kienzle-Horn, S; Peil, H; Schuijt, C; Vix, JM, 2007) |
| "Split 2-L PEG-CS plus bisacodyl was not superior to split 4-L PEG for colonoscopy bowel cleansing in patients with chronic constipation; however, it performed better than the standard regimen in terms of colonic mucosa visualization, patient acceptance and compliance." | 5.20 | 2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipation. ( Arena, M; Baccarin, A; Bargiggia, S; Fontana, P; Manes, G; Masci, E; Mazzoleni, G; Parente, F; Spinzi, G; Testoni, PA; Vailati, C, 2015) |
| "Oral bisacodyl is an effective and well-tolerated treatment for patients with chronic constipation." | 5.15 | Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. ( Gessner, U; Kamm, MA; Mueller-Lissner, S; Richter, E; Swallow, R; Wald, A, 2011) |
| "To compare the safety and efficacy of bisacodyl and sodium picosulphate in the treatment of chronic constipation over a 4-week period." | 5.12 | Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. ( Jordan, CC; Kamm, MA; Kienzle-Horn, S; Peil, H; Schuijt, C; Vix, JM, 2007) |
| "To investigate systemic immunity, the faecal flora and intestinal permeability in patients with chronic constipation, under basal conditions and following therapy with the laxative Bisacodyl." | 3.73 | Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. ( Khalif, IL; Konovitch, EA; Maximova, ID; Quigley, EM, 2005) |
| " Diarrhea, nausea, bloating, and abdominal pain were common adverse events, but no serious adverse events were reported." | 2.72 | Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. ( Brenner, DM; Rao, SSC, 2021) |
| "Chronic constipation is a frequent condition often treated pharmacologically." | 2.49 | Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments. ( Müller-Lissner, S, 2013) |
| " Treatment necessitates long-term intake of laxatives, proper diabetes control and other accompanying general measures such as adequate amounts of liquids, dietary fibre and exercise." | 2.44 | [Constipation in patients with diabetes mellitus]. ( Rossol, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, SJ | 1 |
| Fuller, G | 1 |
| Patel, D | 1 |
| Khalil, C | 1 |
| Spalding, W | 1 |
| Nag, A | 1 |
| Spiegel, BMR | 1 |
| Almario, CV | 1 |
| Rao, SSC | 1 |
| Brenner, DM | 1 |
| Müller-Lissner, S | 1 |
| Parente, F | 1 |
| Vailati, C | 1 |
| Bargiggia, S | 1 |
| Manes, G | 1 |
| Fontana, P | 1 |
| Masci, E | 1 |
| Arena, M | 1 |
| Spinzi, G | 1 |
| Baccarin, A | 1 |
| Mazzoleni, G | 1 |
| Testoni, PA | 1 |
| Nee, J | 1 |
| Feuerstein, JD | 1 |
| Prasad, VG | 1 |
| Abraham, P | 1 |
| Kamm, MA | 2 |
| Mueller-Lissner, S | 1 |
| Wald, A | 1 |
| Richter, E | 1 |
| Swallow, R | 1 |
| Gessner, U | 1 |
| MANDEL, L | 1 |
| SILINSKY, J | 1 |
| Hervé, S | 1 |
| Savoye, G | 1 |
| Behbahani, A | 1 |
| Leroi, AM | 1 |
| Denis, P | 1 |
| Ducrotté, P | 1 |
| Khalif, IL | 1 |
| Quigley, EM | 1 |
| Konovitch, EA | 1 |
| Maximova, ID | 1 |
| Kienzle-Horn, S | 1 |
| Vix, JM | 1 |
| Schuijt, C | 1 |
| Peil, H | 1 |
| Jordan, CC | 1 |
| Rossol, S | 1 |
| Eisen, T | 1 |
| Hotz, J | 1 |
| Stolte, M | 1 |
| Kacere, RD | 1 |
| Srivatsa, SS | 1 |
| Tremaine, WJ | 1 |
| Ebnet, LE | 1 |
| Batts, KP | 1 |
| Bruley Des Varannes, S | 1 |
| Lehur, PA | 1 |
| Henning, H | 1 |
| Vogel, HM | 1 |
| von Braun, HH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Simethicone Pretreatment With Low-volume Polyethylene Glycol-3350 and Bisacodyl in an Effort to Improve Bowel Wall Visualization During Colonoscopy[NCT03410524] | Phase 3 | 250 participants (Actual) | Interventional | 2018-01-09 | Completed | ||
| Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota on Chinese People With Constipation[NCT03100851] | Phase 3 | 62 participants (Actual) | Interventional | 2015-08-02 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for bisacodyl and Chronic Disease
| Article | Year |
|---|---|
Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review.
Topics: Bisacodyl; Cathartics; Chronic Disease; Citrates; Constipation; Defecation; Fruit; Gastrointestinal | 2021 |
Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments.
Topics: Alprostadil; Anthraquinones; Benzofurans; Bisacodyl; Chronic Disease; Constipation; Dose-Response Re | 2013 |
Management of chronic constipation in patients with diabetes mellitus.
Topics: Bisacodyl; Chloride Channel Agonists; Chronic Disease; Citrates; Constipation; Diabetes Complication | 2017 |
[Constipation in patients with diabetes mellitus].
Topics: Bisacodyl; Cathartics; Chronic Disease; Constipation; Diabetes Complications; Diagnosis, Differentia | 2007 |
[Treatment of idiopathic constipation].
Topics: Biofeedback, Psychology; Bisacodyl; Cathartics; Chronic Disease; Colectomy; Colon, Sigmoid; Constipa | 2001 |
3 trials available for bisacodyl and Chronic Disease
| Article | Year |
|---|---|
2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipation.
Topics: Aged; Bisacodyl; Cathartics; Chronic Disease; Citric Acid; Colon; Colonoscopy; Constipation; Female; | 2015 |
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation.
Topics: Administration, Oral; Adult; Aged; Bisacodyl; Cathartics; Chronic Disease; Constipation; Double-Blin | 2011 |
Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Bisacodyl; Cathartics; Chronic Disease; Citrates; Consti | 2007 |
8 other studies available for bisacodyl and Chronic Disease
| Article | Year |
|---|---|
Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy.
Topics: Adult; Age Factors; Bisacodyl; Chronic Disease; Colonoscopy; Constipation; Dietary Fiber; Dioctyl Su | 2020 |
Review: Prucalopride, velusetrag, bisacodyl, and sodium picosulfate improve chronic idiopathic constipation.
Topics: Benzofurans; Bisacodyl; Chronic Disease; Citrates; Constipation; Humans; Organometallic Compounds; P | 2016 |
Bisacodyl (dulcolax): an evacuant supporsitory. A controlled therapeutic trial in chronically ill and geriatric patients.
Topics: Bisacodyl; Cathartics; Chronic Disease; Geriatrics; Humans; Patients | 1960 |
Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation.
Topics: Adult; Aged; Area Under Curve; Bisacodyl; Chronic Disease; Cohort Studies; Colon; Constipation; Fema | 2004 |
Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation.
Topics: Bifidobacterium; Bisacodyl; Cathartics; Cell Membrane Permeability; Chronic Disease; Colon; Constipa | 2005 |
[Diagnosis of factitious diarrhea (Munchausen syndrome) by colon biopsy].
Topics: Biopsy; Bisacodyl; Chronic Disease; Colon; Diagnosis, Differential; Diarrhea; Factitious Disorders; | 1994 |
Chronic diarrhea due to surreptitious use of bisacodyl: case reports and methods for detection.
Topics: Adult; Bisacodyl; Chronic Disease; Diarrhea; Female; Humans; Middle Aged; Prospective Studies; Self | 1993 |
[Hepatotoxicity of laxatives. Further results due to exposure to phenolisatines and bisacodyl].
Topics: Bisacodyl; Cathartics; Chemical and Drug Induced Liver Injury; Cholestasis; Chronic Disease; Female; | 1974 |